Skip to main content
. Author manuscript; available in PMC: 2015 Jun 30.
Published in final edited form as: J Clin Oncol. 2008 May 1;26(13):2186–2191. doi: 10.1200/JCO.2007.14.3552

Figure 3.

Figure 3

Event-free survival (EFS) estimates of patients with TEL rearrangements compared with those of patients with germline TEL and either rapid early responses to therapy (A) or slow early responses (B).